Skip to Main Content

Author Details

Drew Moghanaki
University of California Los Angeles
2000
90
19
PMIDPaper TitleJournal TitlePublished Year
36455397Sins of omission: A meta-research study evaluating the omission of operability in published retrospective comparisons of surgery with stereotactic body radiotherapy in patients with early-stage non-small cell lung cancer.Lung Cancer2023
37568732Predicting Overall Survival for Patients with Malignant Mesothelioma Following Radiotherapy via Interpretable Machine Learning.Cancers (Basel)2023
37674596Rural barriers and facilitators of lung cancer screening program implementation in the veterans health administration: a qualitative study.Front Health Serv2023
37599046Unresectable Stage III NSCLC Should Not be Treated With Neoadjuvant Therapy and Re-Evaluated for Resection.J Thorac Oncol2023
35607930Impact of concomitant fibrates on immunotherapy outcomes for advanced non-small cell lung cancer.Cancer Med2023
37224985The Association of Organizational Readiness With Lung Cancer Screening Utilization.Am J Prev Med2023
36923158Brief Report: Severe Pneumonitis After Combined Thoracic Radiotherapy and Osimertinib.JTO Clin Res Rep2023
36804711The Association of Improved Overall Survival with NSAIDs in Non-Small Cell Lung Cancer Patients Receiving Immune Checkpoint Inhibitors.Clin Lung Cancer2023
36635719Using the Framework for Reporting Adaptations and Modifications-Expanded (FRAME) to study adaptations in lung cancer screening delivery in the Veterans Health Administration: a cohort study.Implement Sci Commun2023
35033300Association of Rurality With Annual Repeat Lung Cancer Screening in the Veterans Health Administration.J Am Coll Radiol2022
35704975De-escalating adjuvant durvalumab treatment duration in stage III non-small cell lung cancer.Eur J Cancer2022
35694034Characterizing Twitter Influencers in Radiation Oncology.Adv Radiat Oncol2022
35982653Using the Framework for Reporting Adaptations and Modifications-Expanded (FRAME) to study lung cancer screening adaptations in the Veterans Health Administration.Res Sq2022
35289111Outcomes following radical prostatectomy or external beam radiation for veterans with Gleason 9 and 10 prostate cancer.Cancer Med2022
35158881Real World Outcomes versus Clinical Trial Results of Durvalumab Maintenance in Veterans with Stage III Non-Small Cell Lung Cancer.Cancers (Basel)2022
35101193Performing SBRT in the Fly-With-Caution Zone: Are We Heeding the Advice of Daedalus?Int J Radiat Oncol Biol Phys2022
35093293Association of Operability With Post-Treatment Mortality in Early-Stage Non-Small Cell Lung Cancer.Clin Lung Cancer2022
32520848The Regimen of Computed Tomography Screening for Lung Cancer: Lessons Learned Over 25 Years From the International Early Lung Cancer Action Program.J Thorac Imaging2021
33851065An International Expert Survey on the Indications and Practice of Radical Thoracic Reirradiation for Non-Small Cell Lung Cancer.Adv Radiat Oncol2021
34409207Use and Outcomes of SBRT for Early Stage NSCLC Without Pathologic Confirmation in the Veterans Health Care Administration.Adv Radiat Oncol2021
34703954Influence of Timing Between Androgen Deprivation Therapy and External Beam Radiation Therapy in Patients With Localized, High-Risk Prostate Cancer.Adv Radiat Oncol2021
34417136Patient-reported outcomes after Low-dose-rate versus High-dose-rate brachytherapy boost in combination with external beam radiation for intermediate and high risk prostate cancer.Brachytherapy2021
34098977Outcomes with multi-disciplinary management of central lung tumors with CT-guided percutaneous high dose rate brachyablation.Radiat Oncol2021
33422974Protocol to evaluate an enterprise-wide initiative to increase access to lung cancer screening in the Veterans Health Administration.Clin Imaging2021
33421372Organizational Readiness for Lung Cancer Screening: A Cross-Sectional Evaluation at a Veterans Affairs Medical Center.J Am Coll Radiol2021
32433897Longitudinal Health-related Quality of Life among Individuals Considering Treatment for Stage I Non-Small-Cell Lung Cancer.Ann Am Thorac Soc2020
32085930Rectal spacing, prostate coverage, and periprocedural outcomes after hydrogel spacer injection during low-dose-rate brachytherapy implantation.Brachytherapy2020
31837477Assessing the Variability and Quality of Lung Stereotactic Radiation Therapy Treatment Plans Using a Web-Based Crowdsourcing Platform.Pract Radiat Oncol2020
33301015Analysis of Radiation Facility Volume and Survival in Men With Lymph Node-Positive Prostate Cancer Treated With Radiation and Androgen Deprivation Therapy.JAMA Netw Open2020
33209461Prophylactic cranial irradiation or MRI surveillance for extensive stage small cell lung cancer.J Thorac Dis2020
32974208Moderately Hypofractionated Intensity Modulated Radiation Therapy With Simultaneous Integrated Boost for Prostate Cancer: Five-Year Toxicity Results From a Prospective Phase I/II Trial.Front Oncol2020
32908355Strategic Initiatives for Veterans with Lung Cancer.Fed Pract2020
32674913Authors' response.Brachytherapy2020
32952386Radiotherapeutic Care of Patients With Stage IV Lung Cancer with Thoracic Symptoms in the Veterans Health Administration.Fed Pract2020
32360578Alternative Multidisciplinary Management Options for Locally Advanced NSCLC During the Coronavirus Disease 2019 Global Pandemic.J Thorac Oncol2020
32433987The Quality of Peer-Reviewed Publications on Surgery for Early Stage Lung Cancer Within the Veterans Health Administration.Semin Thorac Cardiovasc Surg2020
30563669Safeguarding Autonomy of Patients With Bladder Cancer.Int J Radiat Oncol Biol Phys2019
31673515The current and future landscape of radiotherapy for lung cancer.Transl Lung Cancer Res2019
32038926Local consolidative therapy for oligometastatic patients with stage IV non-small cell lung cancer may improve survival, but unanswered questions remain.Transl Lung Cancer Res2019
30919165Trends in Management of Oligometastatic Hormone-Sensitive Prostate Cancer.Curr Oncol Rep2019
31036926Validity of the National Death Index to ascertain the date and cause of death in men having undergone prostatectomy for prostate cancer.Prostate Cancer Prostatic Dis2019
27438691A Phase II Study to Prevent Radiation-induced Rectal Injury With Lovastatin.Am J Clin Oncol2018
30100162Quality Improvements of Veterans Health Administration Radiation Oncology Services Through Partnership for Accreditation With the ACR.J Am Coll Radiol2018
29904736Lung cancer specialists' opinions on treatment for stage I non-small cell lung cancer: A multidisciplinary survey.Adv Radiat Oncol2018
30064301Stereotactic Body Radiotherapy for Primary Prostate Cancer.Technol Cancer Res Treat2018
30370147Collaborating to assess the role of stereotactic body radiation therapy in medically operable stage I non-small cell lung cancer.J Thorac Dis2018
29764185Management of metastatic spinal cord compression among Veterans Health Administration radiation oncologists.Ann Palliat Med2018
29372236Comparison Between Adjuvant and Early-Salvage Postprostatectomy Radiotherapy for Prostate Cancer With Adverse Pathological Features.JAMA Oncol2018
29209835Patient-clinician communication among patients with stage I lung cancer.Support Care Cancer2018
29309549The great debate flashes: surgery versus stereotactic body radiotherapy as the primary treatment of early-stage lung cancer.Eur J Cardiothorac Surg2018
  • 1 - 50 of 90

Recommended Authors

Robert T Dess
University of Michigan ann arbor
Career Start Year 2016
Number of shared co-authors 17
Hilary P Bagshaw
Stanford University
Career Start Year 2014
Number of shared co-authors 8
Erqi L Pollom
Stanford University
Career Start Year 2014
Number of shared co-authors 9
Andrew Warner
Western University and London Regional Cancer Program
Career Start Year 2013
Number of shared co-authors 5
Soumyajit Roy
Rush University Medical Center
Career Start Year 2013
Number of shared co-authors 12
Rachel M Glicksman
University of Toronto, Princess Margaret Cancer Centre, University Health Network
Career Start Year 2013
Number of shared co-authors 7
Darlene Veruttipong
Stanford University
Career Start Year 2012
Number of shared co-authors 5
Nicholas G Zaorsky
University Hospitals Seidman Cancer Centre, Cleveland Medical Centre
Career Start Year 2012
Number of shared co-authors 19
Matthew P Deek
Rutgers Robert Wood Johnson Medical School, Rutgers University
Career Start Year 2011
Number of shared co-authors 8
Hanbo Chen
University of Toronto
Career Start Year 2010
Number of shared co-authors 1
Christine Massey
Princess Margaret Cancer Centre
Career Start Year 2010
Number of shared co-authors 0
Ting Martin Ma
University of Washington
Career Start Year 2010
Number of shared co-authors 14
Chen Hu
Johns Hopkins University School of Medicine
Career Start Year 2009
Number of shared co-authors 5
Amar U Kishan
University of California los angeles
Career Start Year 2008
Number of shared co-authors 27
Bradley J Stish
Mayo Clinic
Career Start Year 2007
Number of shared co-authors 16
Sunita Ghosh
Cross Cancer Institute
Career Start Year 2006
Number of shared co-authors 0
Himanshu Nagar
New York-Presbyterian Hospital, Weill Cornell Medical Center
Career Start Year 2005
Number of shared co-authors 4
Eyad Abu-Isa
Ascension Providence Hospital
Career Start Year 2005
Number of shared co-authors 8
Neil B Desai
University of Texas Southwestern Medical Center
Career Start Year 2004
Number of shared co-authors 5
Zhigang Zhang
Memorial Sloan Kettering Cancer Center
Career Start Year 2001
Number of shared co-authors 2
Amit Bahl
University Hospitals Bristol and Weston NHS Foundation Trust
Career Start Year 2001
Number of shared co-authors 2
Gregory R Pond
Juravinski Hospital and Cancer Centre, Escarpment Cancer Research Institute
Career Start Year 2001
Number of shared co-authors 3
Chiaojung Jillian Tsai
Memorial Sloan Kettering Cancer Center
Career Start Year 2000
Number of shared co-authors 3
Chandana A Reddy
Cleveland Clinic
Career Start Year 2000
Number of shared co-authors 12
Constantine A Mantz
University of Chicago
Career Start Year 1997
Number of shared co-authors 9
Puneeth Iyengar
UT Southwestern Medical Center, Center for Human Nutrition
Career Start Year 1996
Number of shared co-authors 5
Jonathan D Tward
Huntsman Cancer Institute, University of Utah
Career Start Year 1994
Number of shared co-authors 12
Theodore L DeWeese
Johns Hopkins University School of Medicine
Career Start Year 1991
Number of shared co-authors 15
Anthony V D'Amico
Duke University Medical Center
Career Start Year 1988
Number of shared co-authors 17
Andre Konski
Chester County Hospital
Career Start Year 1982
Number of shared co-authors 7

Collaborators

Claudia I Henschke
Icahn School of Medicine at Mount Sinai
Co-authored papers 8
David F Yankelevitz
Icahn School of Medicine at Mount Sinai
Co-authored papers 8
Bridget F Koontz
Duke University School of Medicine
Co-authored papers 7
Jennifer A Lewis
Vanderbilt-Ingram Cancer Center
Co-authored papers 7
Lucy B Spalluto
Vanderbilt-Ingram Cancer Center, and Education Clinical Center (GRECC)
Co-authored papers 7
Christopher G Slatore
Health Services Research & Development
Co-authored papers 7
Christianne L Roumie
Vanderbilt University Medical Center
Co-authored papers 7
Timothy J Vogus
Vanderbilt University
Co-authored papers 6
Robert S Dittus
12328Vanderbilt University Medical Center
Co-authored papers 6
Christopher J Lindsell
Duke University
Co-authored papers 5
Carolyn M Audet
Vanderbilt University Medical Center (VUMC), Institute for Global Health
Co-authored papers 5
Sunil Kripalani
Section of Hospital Medicine, Vanderbilt University Medical Center
Co-authored papers 5
Neha Vapiwala
Abramson Cancer Center, University of Pennsylvania
Co-authored papers 5
William Robert Lee
Duke University School of Medicine
Co-authored papers 4
Charles R Thomas
Oregon Health & Science University
Co-authored papers 4
Alan Pollack
University of Miami Miller School of Medicine
Co-authored papers 4
Carol Callaway-Lane
Tennessee Valley Healthcare System
Co-authored papers 4
Robert B Den
Thomas Jefferson University Hospital
Co-authored papers 4
Stephen J Freedland
Cedars-Sinai Medical Center
Co-authored papers 4
Thomas M Pisansky
Mayo Clinic
Co-authored papers 4
Rahul D Tendulkar
Taussig Cancer Institute, Cleveland Clinic
Co-authored papers 4
Jeff M Michalski
Washington University School of Medicine
Co-authored papers 4
David A Palma
University of Western Ontario
Co-authored papers 3
Pierre P Massion
Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
Co-authored papers 3
Michael Matheny
American College of Medical Informatics, Department of Veteran Affairs, Harvard University T H Chan School of Public Health, Massachusetts Institute of Technology, The American Society for Clinical Investigation, University of Kentucky, Vanderbilt University Medical Center, Vanderbilt University Medical School
Co-authored papers 2
Nicholas van As
The Institute of Cancer Research, Royal Marsden NHS Foundation Trust
Co-authored papers 2
Arun J Sanyal
Virginia Commonwealth University
Co-authored papers 2
Juan P Wisnivesky
Co-authored papers 2
Daniel E Spratt
University Hospitals Seidman Cancer Center, Case Western Reserve University
Co-authored papers 2
Nikhil T Sebastian
Emory University
Co-authored papers 2
Release 1.2